Drug
Ops 2071
Ops 2071: highest development phase Phase 2, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| OPS-2071 NCT03850509 | Phase 2 | Crohn's Disease |
Latest
No recent events.
Follow Ops 2071 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.